Target intelligence / Profile preview

MicroRNA 1284 (miR-1284)

Target
miR-1284
Molecular classification
Non-coding RNA, MicroRNA
01

Overview

MicroRNA 1284 (miR-1284) is a short non-coding RNA (20–24 nucleotides) classified as a microRNA, involved in the post-transcriptional regulation of gene expression by binding to target mRNAs, leading to inhibition of translation or mRNA destabilization[2]. miR-1284 has functional roles in the regulation of cell proliferation, apoptosis, and cell cycle progression, particularly in cancer contexts. Experimental studies demonstrate that miR-1284 inhibits growth and induces apoptosis in lung cancer cells, likely through the modulation of key proteins such as Myc, p27, Bax, and caspase-3[1]. Increased miR-1284 levels enhance chemosensitivity, including when co-delivered with cisplatin in experimental systems, suggesting a potential therapeutic target for overcoming drug resistance[4]. As a microRNA, miR-1284 is not a protein-coding gene, enzyme, or receptor, but rather a regulator with broad functional impact in post-transcriptional gene networks[1][2].

Other names
hsa-mir-1284MIRN1284MIR1284mir-1284
02

Mechanism of action

Modulation of chemosensitivity via enhancement of apoptosis when co-delivered with chemotherapeutic agents (e.g., cisplatin)[4]

03

Biological functions

Post-transcriptional gene regulationRegulation of mRNA stabilityRegulation of mRNA translationCell proliferationApoptosis
04

Disease associations

Cancer (roles supported in lung cancer and chemoresistance contexts)Possible role in lung tumorigenesis
05

Safety considerations

As an endogenous microRNA, major safety/therapeutic challenges involve delivery, specificity, and potential off-target gene regulation when used as a therapeutic
06

Interacting drugs

Cisplatin (in the context of experimental delivery, not a direct molecular interaction)[4]
07

Biomarkers

Altered expression levels in tumor tissue may be explored as a biomarker for cancer presence or response to therapy (preclinical evidence)[1]

Beyond the preview

Go deeper on MicroRNA 1284 (miR-1284).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1284 (miR-1284).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call